Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment
Clinical trial NCT07545486 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07545486
- Sponsor
- Chirec
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-01
- Primary completion
- 2033-06-01
- Enrollment
- 1235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.